Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Embecta Corp.

EMBCVNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$33.33
$-3.43(-9.33%)
U.S. Market opens in 15h 30m

Embecta Corp. (EMBCV) Stock Overview

Explore Embecta Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.9B
P/E Ratio0.00
EPS (TTM)N/A
ROE-0.28%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

EMBCV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Embecta Corp. (EMBCV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 1.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
-29.09%
3-Year Change
-29.09%
5-Year Change
-29.09%
All-Time (Max) Change
-29.09%

Contact Information

(201) 847-6800
1 Becton Drive, Franklin Lakes, NJ, 07054

Company Facts

20,290 Employees
IPO DateMar 21, 2022
CountryUS

Frequently Asked Questions